I think Taimoor164 makes a fair point for exactly the reasons you have mentioned col69. As you have said, the current share price really only reflects the likely sales generated by Ryoncil if/when approved. While I wouldn’t want to see large gaps created by a rapid share price rise due to the recent announcement, I am surprised to see meso trend downwards on the 2nd day post announcement. As a health care practitioner I have a comprehensive understanding of the mechanism of action for mesoblasts stem cell therapies and am 100% certain that the vast majority of mesoblasts therapies will have positive results, however the underlying potential of this stock is not being reflected in the share price and I can see why some are frustrated or confused. I believe this is predominantly due to a general lack of pathophysiological knowledge surrounding stem cell therapy among the vast majority of investors and just using this company as a short term/day trading stock. hoping to see the potential of this stock and it’s treatments publicised more widely to get more investors on-board.
- Forums
- ASX - By Stock
- MSB
- MESO Nasdaq update
MESO Nasdaq update, page-280
-
-
- There are more pages in this discussion • 5,240 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.10 |
Change
-0.025(2.23%) |
Mkt cap ! $1.250B |
Open | High | Low | Value | Volume |
$1.13 | $1.16 | $1.04 | $14.57M | 13.49M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 21024 | $1.09 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.10 | 241 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8000 | 1.130 |
2 | 2036 | 1.100 |
2 | 2726 | 1.095 |
2 | 28270 | 1.090 |
2 | 12608 | 1.085 |
Price($) | Vol. | No. |
---|---|---|
1.095 | 2241 | 2 |
1.100 | 8250 | 3 |
1.105 | 25067 | 2 |
1.110 | 38800 | 8 |
1.115 | 28657 | 2 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |